India News | Reported by Sukirti Dwivedi, Edited by Vaibhav Tiwari | Friday December 11, 2020
An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
www.ndtv.com